197 related articles for article (PubMed ID: 17652808)
1. Ongoing phase I and II studies of novel anthracyclines.
Sessa C; Valota O; Geroni C
Cardiovasc Toxicol; 2007; 7(2):75-9. PubMed ID: 17652808
[TBL] [Abstract][Full Text] [Related]
2. Role of anthracyclines in the era of targeted therapy.
Cortés-Funes H; Coronado C
Cardiovasc Toxicol; 2007; 7(2):56-60. PubMed ID: 17652804
[TBL] [Abstract][Full Text] [Related]
3. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity.
Minotti G; Menna P; Salvatorelli E; Cairo G; Gianni L
Pharmacol Rev; 2004 Jun; 56(2):185-229. PubMed ID: 15169927
[TBL] [Abstract][Full Text] [Related]
4. Cardiac safety of liposomal anthracyclines.
Batist G
Cardiovasc Toxicol; 2007; 7(2):72-4. PubMed ID: 17652807
[TBL] [Abstract][Full Text] [Related]
5. Genotyping the risk of anthracycline-induced cardiotoxicity.
Deng S; Wojnowski L
Cardiovasc Toxicol; 2007; 7(2):129-34. PubMed ID: 17652817
[TBL] [Abstract][Full Text] [Related]
6. An introduction to the metabolic determinants of anthracycline cardiotoxicity.
Menna P; Recalcati S; Cairo G; Minotti G
Cardiovasc Toxicol; 2007; 7(2):80-5. PubMed ID: 17652809
[TBL] [Abstract][Full Text] [Related]
7. Utility of dexrazoxane for the reduction of anthracycline-induced cardiotoxicity.
Jones RL
Expert Rev Cardiovasc Ther; 2008 Nov; 6(10):1311-7. PubMed ID: 19018683
[TBL] [Abstract][Full Text] [Related]
8. Other uses of dexrazoxane: Savene, the first proven antidote against anthracycline extravasation injuries.
Langer SW; Jensen PB; Sehested M
Cardiovasc Toxicol; 2007; 7(2):151-3. PubMed ID: 17652821
[TBL] [Abstract][Full Text] [Related]
9. Anthracycline-induced cardiotoxicity: comparison of recommendations for monitoring cardiac function during therapy in paediatric oncology trials.
van Dalen EC; van den Brug M; Caron HN; Kremer LC
Eur J Cancer; 2006 Dec; 42(18):3199-205. PubMed ID: 17011186
[TBL] [Abstract][Full Text] [Related]
10. Long-term and short-term models for studying anthracycline cardiotoxicity and protectors.
Robert J
Cardiovasc Toxicol; 2007; 7(2):135-9. PubMed ID: 17652818
[TBL] [Abstract][Full Text] [Related]
11. Rodorubicin, a new tetraglycosidic anthracycline.
Kraemer HP; Sedlacek HH
Behring Inst Mitt; 1988 Apr; (82):216-30. PubMed ID: 3165634
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and metabolism of anthracyclines.
Robert J; Gianni L
Cancer Surv; 1993; 17():219-52. PubMed ID: 8137342
[TBL] [Abstract][Full Text] [Related]
13. Dose optimization of anthracyclines.
de Valeriola D
Anticancer Res; 1994; 14(6A):2307-13. PubMed ID: 7825964
[TBL] [Abstract][Full Text] [Related]
14. [One case report of a late cardiotoxicity after administration of low doses of anthracyclines].
Lawson L; Masmoudi K; Fry P; Andrejak M
Therapie; 2010; 65(3):269-70. PubMed ID: 20699083
[No Abstract] [Full Text] [Related]
15. Role of mtDNA lesions in anthracycline cardiotoxicity.
Lebrecht D; Walker UA
Cardiovasc Toxicol; 2007; 7(2):108-13. PubMed ID: 17652814
[TBL] [Abstract][Full Text] [Related]
16. Recovery from anthracycline cardiomyopathy--how can it be explained?
Christiansen S
J Heart Lung Transplant; 2009 Jul; 28(7):751. PubMed ID: 19560709
[No Abstract] [Full Text] [Related]
17. Protection by flavonoids against anthracycline cardiotoxicity: from chemistry to clinical trials.
Bast A; Haenen GR; Bruynzeel AM; Van der Vijgh WJ
Cardiovasc Toxicol; 2007; 7(2):154-9. PubMed ID: 17652822
[TBL] [Abstract][Full Text] [Related]
18. [Oxidative stress after anthracycline therapy in patients with solid tumors].
Kocik M; Zimovjanova M; Petruzelka L; Kodydkova J; Vavrova L; Zak A
Cas Lek Cesk; 2012; 151(10):463-7. PubMed ID: 23256630
[TBL] [Abstract][Full Text] [Related]
19. Anthracycline therapy may be avoidable in early breast cancer, new studies suggest.
Tuma R
J Natl Cancer Inst; 2008 Apr; 100(7):459-61. PubMed ID: 18364497
[No Abstract] [Full Text] [Related]
20. [Cardiotoxicity in anthracycline chemotherapy: significance of infusion durations. Analysis of a Cochrane review].
Appel JM; Rybjerg M; Nielsen DL
Ugeskr Laeger; 2007 Sep; 169(37):3105-7. PubMed ID: 17877960
[No Abstract] [Full Text] [Related]
[Next] [New Search]
